DaVita Inc. DVA
NYSE · Healthcare · Medical - Care Facilities
$161.03
Close on Fri, 20 Nov 2026 · market value $10.1B
What the price is betting on
Below its recordAt $161, the price assumes revenue shrinks about 12% a year for five years, from $14.2B to about $8.2B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 8.5% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than DVA? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$337
Base
$377
Bull
$422
Today $161
- Bear $337. Cash flow grows 1% a year for the next 5 years, slower than expected, then slows to long-run growth.
- Base $377. Cash flow grows 3% a year for the next 5 years, as analysts expect, then slows to long-run growth.
- Bull $422. Cash flow grows 5% a year for the next 5 years, faster than expected, then slows to long-run growth.
Stories set by rules from the company’s record.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$13.7B$14.2B, on the path
- FY2027$12.1B$14.7B, on the path
- FY2028$10.6B$15.2B, on the path
- FY2029$9.4B$16.3B, on the path
- FY2030$8.2B$17.2B, on the path
Each year's revenue at −12% growth from $14.2B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Care Facilities · listed on NYSE
- Revenue, FY2025
- $13.6B
- Growth, 3 years a year
- 5.8%
- Cash margin
- 9.6%
- Net debt
- $14.3B
- Shares, 3-year change
- −21%
- Dividend yield
- 0%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.